American Heart Journal
Volume 160, Issue 2 , Pages 250-256.e3 , August 2010

Joint effects of common genetic variants from multiple genes and pathways on the risk of premature coronary artery disease

  • Jeffrey L. Anderson, MD

      Affiliations

    • Cardiovascular Department, Intermountain Medical Center, Murray, UT
    • Cardiovascular Genetics, University of Utah School of Medicine, Salt Lake City, UT
    • Corresponding Author InformationReprint requests: Jeffrey L. Anderson, MD, Intermountain Medical Center; Cardiovascular Department. 5121 S. Cottonwood Street, Murray, UT 84107.
    • ,
  • Benjamin D. Horne, PhD, MPH

      Affiliations

    • Cardiovascular Department, Intermountain Medical Center, Murray, UT
    • Genetic Epidemiology Divisions, University of Utah School of Medicine, Salt Lake City, UT
    • ,
  • Nicola J. Camp, PhD

      Affiliations

    • Genetic Epidemiology Divisions, University of Utah School of Medicine, Salt Lake City, UT
    • ,
  • Joseph B. Muhlestein, MD

      Affiliations

    • Cardiovascular Department, Intermountain Medical Center, Murray, UT
    • Cardiovascular Genetics, University of Utah School of Medicine, Salt Lake City, UT
    • ,
  • Paul N. Hopkins, MD, MPH

      Affiliations

    • Cardiovascular Genetics, University of Utah School of Medicine, Salt Lake City, UT
    • ,
  • Lisa A. Cannon-Albright, PhD

      Affiliations

    • Genetic Epidemiology Divisions, University of Utah School of Medicine, Salt Lake City, UT
    • ,
  • Chrissa P. Mower, BS

      Affiliations

    • Cardiovascular Department, Intermountain Medical Center, Murray, UT
    • ,
  • James J. Park, BA

      Affiliations

    • Cardiovascular Department, Intermountain Medical Center, Murray, UT
    • ,
  • Jessica L. Clarke, BS

      Affiliations

    • Cardiovascular Department, Intermountain Medical Center, Murray, UT
    • ,
  • Zachary P. Nicholas, BS

      Affiliations

    • Cardiovascular Department, Intermountain Medical Center, Murray, UT
    • ,
  • Jason T. McKinney, PhD

      Affiliations

    • Idaho Technology, Salt Lake City, UT
    • ,
  • John F. Carlquist, PhD

      Affiliations

    • Cardiovascular Department, Intermountain Medical Center, Murray, UT
    • Cardiovascular Genetics, University of Utah School of Medicine, Salt Lake City, UT

Received 23 December 2009 ,Accepted 19 May 2010.

References 

  1. Hopkins PN, Hunt SC, Wu LL. Family history and genetic factors. In:  Wong ND,  Black HR,  Gardin JM editor. Preventive cardiology, a practical approach. New York: McGraw-Hill; 2005;p. 92–148
  2. Anderson JL, Carlquist JF, Horne BD, et al. Progress in unraveling the genetics of coronary artery disease and myocardial infarction. Current Atherosclerosis Reports. 2007;9:179–186
  3. Hirschhorn JN. Genomewide association studies—illuminating biologic pathways. N Engl J Med. 2009;360:1699–1701
  4. Topol EJ, Smith J, Plow EF, et al. Genetic susceptibility to myocardial infarction and coronary artery disease. Hum Molec Genet. 2006;15:R117–R123
  5. Horne BD, Anderson JL, Carlquist JF, et al. Generating genetic risk scores from intermediate phenotypes for use in association studies of clinically significant endpoints. Ann Human Genetics. 2005;69:176–186
  6. Piccolo SR, Abo RP, Allen-Brady BK, et al. Evaluation of genetic risk scores for lipid levels using genome wide markers in the Framingham Heart Study. BMC. 2009;3(Suppl 7):546
  7. Kathiresan S, Melander O, Anevski D, et al. Polymorphisms associated with cholesterol and risk of cardiovascular events. N Engl J Med. 2008;358:1240–1249
  8. Taylor GS, Muhlestein JB, Wagner GS, et al. Implementation of a computerized cardiovascular information system in a private hospital setting. Am Heart J. 1998;136:792–803
  9. Horne BD, Camp NJ, Carlquist JF, et al. Multiple-polymorphism associations of seven matrix metalloproteinase and tissue inhibitor metalloproteinase genes with myocardial infarction and angiographic coronary artery disease. Am Heart J. 2007;154:751–758
  10. Horne BD, Carlquist JF, Muhlestein JB, et al. Association of variation in the chromosome 9p21 locus with myocardial infarction versus chronic coronary artery disease. Circulation Cardiovascular Genetics. 2008;1:85–92
  11. Horne BD, Carlquist JF, Cannon-Albright LA, et al. High-resolution characterization of linkage disequilibrium structure and selection of tagging SNPs for the cholesteryl ester transfer protein gene. Ann Human Genetics. 2006;70:524–534
  12. Horne BD, Camp NJ, Anderson JL, et al. Multiple less common genetic variants explain the association of the cholesteryl ester transfer protein gene with coronary artery disease. J Am Coll Cardiol. 2007;49:2053–2060
  13. Cornelis MC, Qi L, Zhang C, et al. Joint effects of common genetic variants on the risk of type 2 diabetes in U.S. men and women of European ancestry. Ann Intern Med. 2009;150:541–550
  14. Horne BD, Camp NJ, Carlquist JF, et al. Modeling multiplicative SNP interactions in the presence of an additive genetic risk score. Genet Epidemiol. 2009;33:771
  15. Balding DJ. A tutorial on statistical methods for population association studies. Nat Rev Genet. 2006;7:781–791
  16. Pencina JJ, D'Agostino RBS, D'Agostino RBJ, et al. Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond. Statist Med. 2008;27:157–172
  17. Hlatky MA, Greenland P, Arnett DK, et al. Criteria for evaluation of novel markers of cardiovascular risk: a scientific statement from the American Heart Association. Circulation. 2009;119:2408–2416
  18. Ridker PM, Buring JE, Rifai N, et al. Development and validation of improved algorithms for the assessment of global cardiovascular risk in women. JAMA. 2007;297:611–619
  19. Cook NR. Use and misuse of receiver operating characteristic curves in risk prediction. Circulation. 2007;115:928–935
  20. Cook NR, Ridker PM. Advances in measuring the effect of individual predictors of cardiovascular risk: the role of reclassification measures. Ann Intern Med. 2009;150:795–802
  21. Goldstein DB. Common genetic variation and human traits. N Engl J Med. 2009;360:1696–1698
  22. Kraft P, Hunter DJ. Genetic risk prediction—are we there yet?. N Engl J Med. 2009;360:1701–1703
  23. Lander ES. The new genomics: global views of biology. Science. 1996;274:536–539
  24. Anderson JL, Horne BD, Kolek MJ, et al. Genetic variation at the 9p21 locus predicts angiographic coronary artery disease prevalence but not extent and has clinical utility. Am Heart J. 2008;156:1155–1162
  25. Dandona S, Stewart AFR, Chen L, et al. Gene dosage of the common variant 9p21 predicts severity of coronary artery disesae. J Am Coll Cardiol. 2010;56:[in press]
  26. Talmud PJ, Cooper JA, Palmen J, et al. Chromosome 9p21.3 coronary heart disease locus genotype and prospective risk of CHD in healthy middle-aged men. Clin Chem. 2008;54:467–474
  27. Brautbar A, Ballantyne CM, Lawson K, et al. Impact of adding a single allele in the 9p21 locus to traditional risk factors on reclassification of coronary heart disease risk and implications for lipid-modifiying therapy in Atherosclerosis Risk in Communities study. Clin Cardiovasc Genet. 2009;2:279–285
  28. Paynter NP, Chasman DI, Buring JE, et al. Cardiovascular disease risk prediction with and without knowledge of genetic variation at chromosome 9p21.3. Ann Intern Med. 2009;150:65–72
  29. Coronary Artery Disease Consortium . Large scale association analysis of novel genetic loci for coronary artery disease. Arterioscl Thromb Vasc Biol. 2009;29:775–780
  30. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report. Circulation. 2002;106:3143–3421

PII: S0002-8703(10)00437-0

doi: 10.1016/j.ahj.2010.05.031

American Heart Journal
Volume 160, Issue 2 , Pages 250-256.e3 , August 2010

Article Tools

* Image Usage & Resolution